VVOS Earnings Date & History
Vivos Therapeutics Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:07 PM ET
Vivos Therapeutics Inc
Health Care
- Next earnings date
- Tuesday, November 17, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.31
- Revenue estimate
- $6.1M
VVOS earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Wednesday, May 20, 2026 | Q1 2026 | $-0.46 | $-0.52 | -12.5% | $5.1M |
| Wednesday, April 15, 2026 | Q4 2025 | $-0.49 | $-0.58 | -17.6% | $3.8M |
| Wednesday, November 19, 2025 | Q3 2025 | $-0.52 | $-0.49 | +5.8% | $6.8M |
| Tuesday, August 19, 2025 | Q2 2025 | $-0.39 | $-0.55 | -40.1% | $3.8M |
What the market is watching in VVOS's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next VVOS earnings date?
- Vivos Therapeutics Inc is scheduled to report on Tuesday, November 17, 2026 (Time TBD). Dates can change until the company confirms them.
- Does VVOS report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for VVOS?
- Consensus EPS for the upcoming quarter is $-0.31, on revenue of $6.1M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
VVOS earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.